Drugs and Devices

FDA warning for terbutaline in preterm labor

The U.S. Food and Drug Administration issued a warning that terbutaline, indicated for asthma, bronchitis, and emphysema, should not be used in pregnant women for prevention or prolonged treatment of preterm labor because it can cause serious maternal heart problems and death. Oral terbutaline tablets should also not be used to the prevention or treatment of preterm labor. Read more here.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares